SureTrader
Home > Boards > US Listed > Biotechs >

ArQule Inc. (ARQL)

ARQL RSS Feed
Add ARQL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 4/17/2018 5:09:03 PM - Followers: 39 - Board type: Free - Posts Today: 0

http://www.arqule.com/

http://finance.yahoo.com/q/h?s=ARQL

http://library.corporate-ir.net/library/82/829/82991/items/251342/ArQuleJune07.pdf

http://www.clinicaltrials.gov/ct/search;jsessionid=6800B95BD4EAC4F758634AECE97FE6F8?term=arqule

ArQule, Inc., a clinical-stage biotechnology company, engages in the research and development of cancer therapeutics directed toward molecular targets. Its lead product ARQ 197 is an orally administered inhibitor of the c-Met receptor tyrosine kinase, which is being evaluated as monotherapy and in combination therapy in a Phase II clinical development program that includes trials in microphthalmia transcription factor associated tumors, non-small cell lung cancer, pancreatic adenocarcinoma, and hepatocellular carcinoma. The company?s clinical stage products also include ARQ 501, ARQ 761, and ARQ 171, which are designed to kill cancer cells selectively while sparing normal cells through the direct activation of DNA damage response/checkpoint pathways. It?s preclinical and discovery programs comprise ARQ 621 focused on inhibition of the Eg5 kinesin spindle protein; ARQ 761, a second-generation E2F-1 activator; and BRAF and AKIP Kinase inhibitors. The company has collaborations with Kyowa Hakko Kirin Co., Ltd. and Daiichi Sankyo Co., Ltd. ArQule, Inc. was founded in 1993 and is headquartered in Woburn, Massachusetts.

SureTrader
ARQL
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
ARQL News: Current Report Filing (8-k) 04/17/2018 07:31:58 AM
ARQL News: ArQule & Basilea Enter into Exclusive License Agreement for Derazantinib in the US, EU, Japan & Rest of World Excluding Great... 04/17/2018 07:00:00 AM
ARQL News: Statement of Changes in Beneficial Ownership (4) 04/06/2018 04:55:22 PM
ARQL News: Confidential Treatment Order (ct Order) 04/06/2018 09:07:38 AM
ARQL News: Proxy Statement (definitive) (def 14a) 03/29/2018 07:02:37 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#250   * * $ARQL Video Chart 04-17-18 * * ClayTrader 04/17/18 05:09:03 PM
#249   ARQL $3.09 *** News Out stock1ace1 04/17/18 01:29:09 PM
#248   AR stock1ace1 04/17/18 01:28:41 PM
#247   Abstract. http://www.abstractsonline.com/pp8/#!/4562/presentation/6496 buckiii2 04/13/18 06:43:42 PM
#246   * * $ARQL Video Chart 03-26-18 * * ClayTrader 03/26/18 05:04:38 PM
#245   Whats st? bigjay187 03/26/18 04:38:22 PM
#244   FYI this is on ST but I cannot buckiii2 03/26/18 02:50:41 PM
#243   * * $ARQL Video Chart 03-21-18 * * ClayTrader 03/21/18 04:16:55 PM
#242   * * $ARQL Video Chart 03-16-18 * * ClayTrader 03/16/18 04:58:13 PM
#241   * * $ARQL Video Chart 05-18-17 * * ClayTrader 05/18/17 04:24:06 PM
#240   Price is not being reflected accurately?? Ijohnrob 05/18/17 11:13:03 AM
#239   This thing is moving up!! Ijohnrob 05/18/17 11:11:51 AM
#238   More then 4.5x more buys then sells and chasingpennies 03/30/17 09:22:21 PM
#237   Well its old news from back in feb. chasingpennies 03/27/17 10:34:56 AM
#236   This company sucks. Seems like they can't get chasingpennies 03/27/17 10:23:09 AM
#235   ARQL President Trump touts orphan drugs. gogoyears 02/28/17 09:48:54 PM
#234   ArQule, Inc. (NASDAQ:ARQL)’s Liver Cancer Drug Fails: What’s trendmkr 02/20/17 03:03:28 PM
#233   Sorry, wrong board. Jesspro 02/14/17 11:39:30 PM
#232   What is this Prana1 02/14/17 10:48:48 PM
#231   All gone...accepted tender cash offer of $24. See Jesspro 02/14/17 04:51:48 PM
#230   ARQL 71.12M shares, float 42.79M shares simba1 02/10/17 03:44:13 PM
#229   First Eagle raises stake in ARQL to 16.66%, simba1 02/10/17 03:42:30 PM
#228   $ARQL HHMMM simba1 01/12/17 02:51:57 PM
#227   also news on ARQ 531. Also institutional simba1 12/05/16 11:43:22 AM
#226   News tonight ARQ092 may be a home run! rdsrich 12/03/16 05:58:17 PM
#225   ARQL Decent report. Bright future. Cheap price. simba1 11/07/16 11:54:30 AM
#224   ARQL The pps is beginning to fluctuate at gogoyears 10/24/16 06:57:12 PM
#223   Got in today. Could be getting ready simba1 09/28/16 08:28:55 PM
#222   ARQL Strong uptrend developing. Watch out when it gogoyears 09/26/16 10:57:33 PM
#221   That was released/reported about 6 months ago gogoyears 09/23/16 04:54:32 PM
#220   Where do you see Pfizer? edge 09/23/16 04:26:45 PM
#219   In at 1.45 NathanH 08/30/16 08:13:21 PM
#218   ARQL is caught in the lull before news. gogoyears 08/20/16 09:42:52 AM
#217   I would like to see $2.10 and above jbem777 06/24/16 07:08:11 PM
#216   What's your price target here? Tons of potential imo Bulldog88 06/23/16 03:49:56 PM
#215   This is set to rip in the next jbem777 06/22/16 08:50:34 PM
#214   Added more today. Multiple catalysts this year, with blackdeath 06/22/16 02:35:04 PM
#213   BOOM# CHACCA LACCA gogoyears 06/22/16 01:26:13 AM
#212   New report issued from rising tide equity research blackdeath 06/20/16 11:37:22 AM
#211   ARQL Added more today. Looking forward to next gogoyears 04/29/16 05:21:44 PM
#210   400K block @ $1.80 NY1972 04/20/16 01:26:58 PM
#209   ARQ761 in combination with anti-CTLA4 or anti-PD-L1??? NY1972 04/18/16 09:38:22 PM
#208   combination of a FGFR inhibitor with an AKT NY1972 04/16/16 04:39:50 PM
#207   PARP inhibitor olaparib (Ola) and AKT inhibitor AZD5363 NY1972 04/16/16 04:36:00 PM
#206   ARQL This trail has also been approved to gogoyears 03/25/16 07:57:01 AM
#205   Insiders are buying....pfizer just took a small position camvvv 03/22/16 01:38:02 PM
#204   Insiders are buying....pfizer just took a small position camvvv 03/22/16 01:38:01 PM
#203   2016 will be the year for Arqule. We gogoyears 12/18/15 10:11:51 PM
#202   Set to move. Announcements coming. RealWins 11/29/15 10:20:28 AM
#201   ARQL PSL all over this one! Explosive set Strukture 09/20/15 02:53:29 PM
PostSubject